Hologic, Inc.
HOLX · NASDAQ
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/28/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -5.87 | -0.02 | 1.82 | 1.44 |
| FCF Yield | 0.00% | 2.27% | 0.93% | 0.85% |
| EV / EBITDA | 50.03 | 46.02 | 194.61 | 49.65 |
| Quality | ||||
| ROIC | 2.42% | 2.69% | -0.06% | 2.40% |
| Gross Margin | 60.90% | 56.32% | 37.53% | 56.81% |
| Cash Conversion Ratio | 1.76 | -9.74 | 0.94 | 2.05 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.58% | 0.00% | -0.25% | -3.29% |
| Free Cash Flow Growth | 0.00% | 155.80% | -9.21% | -57.74% |
| Safety | ||||
| Net Debt / EBITDA | 2.11 | 2.36 | 14.34 | 2.15 |
| Interest Coverage | 24.69 | 8.81 | -0.24 | 7.53 |
| Efficiency | ||||
| Inventory Turnover | 0.60 | 0.63 | 0.88 | 0.62 |
| Cash Conversion Cycle | 158.10 | 158.41 | 130.51 | 151.55 |